Cellular disposition of arabinogalactan in primary cultured rat hepatocytes

被引:20
作者
Tanaka, T [1 ]
Fujishima, Y [1 ]
Hamano, S [1 ]
Kaneo, Y [1 ]
机构
[1] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Dept Biopharmaceut, Fukuyama, Hiroshima 7290292, Japan
关键词
arabinogalactan; receptor mediated endocytosis; asialoglycoprotein receptor; drug delivery system; binding affinity; internalization;
D O I
10.1016/j.ejps.2004.04.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To characterize a targeting property of arabinogalactan (AG) as a carrier to the liver, we examined cellular disposition, such as binding and internalization in primary cultured rat hepatocytes, comparing them to those of asialofetuin (AF). A tyramine derivative of AG was synthesized to allow labeling with I-125. Binding of AG to the cells was concentration-dependent and saturable. The number of binding sites (n) of AG on the cell surface was 4.0 x 10(5) +/- 0.1 x 10(5) sites per cell which was about similar to that of AF. The value of K. of AG was 2.2 x 10(8) 0.1 x 10(8) M-1 being seven-fold higher than that of AF. The binding of AG was competitively inhibited by AF and was decreased by calcium depletion. These results indicate that AG can bind strongly to hepatocytes probably through the recognition by the asialoglycoprotein receptor (ASGP-R). Both I-125-labeled AG and fluorescein-labeled AG were internalized into the cells. The rate of internalization of AG was faster than that of AF, indicating that AG is effectively endocytosed. Microscopic observations showed that FITC labeled AG accumulated in granules within the primary cultured rat hepatocytes. Subcellular fractionation indicated that the internalized AG was mainly associated with the lysosomal fraction. However, the internalized AG seemed to remain intact in the hepatocytes. In conclusion, we found that AG is effectively internalized in primary cultured rat hepatocytes. Although AG seems a good candidate for targeting to the liver due to its high affinity binding and rapid internalization, it remains to be established whether the apparent lack of biodegradation will result in cytotoxic effects at chronic administration in vivo. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:435 / 444
页数:10
相关论文
共 33 条
[1]   LYSOSOMOTROPIC AGENTS [J].
DEDUVE, C ;
DEBARSY, T ;
POOLE, B ;
TROUET, A ;
TULKENS, P ;
VANHOOF, F .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (18) :2495-+
[2]   A novel injectable water-soluble amphotericin B-arabinogalactan conjugate [J].
Falk, R ;
Domb, AJ ;
Polacheck, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1975-1981
[3]   TARGETING OF ANTIVIRAL DRUGS TO THE LIVER USING GLYCOPROTEIN CARRIERS [J].
FIUME, L ;
BUSI, C ;
DISTEFANO, G ;
MATTIOLI, A .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) :51-65
[4]   TARGETING OF GENES TO THE LIVER WITH GLYCOPROTEIN CARRIERS [J].
FRESE, J ;
WU, CH ;
WU, GY .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) :137-152
[5]  
FUJISHIMA Y, 1998, P 9 JAP AM C PHARM B
[6]   RECEPTOR-MEDIATED INTRODUCTION OF PEPSTATIN-ASIALOFETUIN CONJUGATE INTO LYSOSOMES OF RAT HEPATOCYTES [J].
FURUNO, K ;
MIWA, N ;
KATO, K .
JOURNAL OF BIOCHEMISTRY, 1983, 93 (01) :249-256
[7]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[8]   ARABINOGALACTAN FOR HEPATIC DRUG-DELIVERY [J].
GROMAN, EV ;
ENRIQUEZ, PM ;
JUNG, C ;
JOSEPHSON, L .
BIOCONJUGATE CHEMISTRY, 1994, 5 (06) :547-556
[9]   Cell-specific delivery of genes with glycosylated carriers [J].
Hashida, M ;
Nishikawa, M ;
Yamashita, F ;
Takakura, Y .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) :187-196
[10]   A FUNCTIONALIZED SUPERPARAMAGNETIC IRON-OXIDE COLLOID AS A RECEPTOR DIRECTED MR CONTRAST AGENT [J].
JOSEPHSON, L ;
GROMAN, EV ;
MENZ, E ;
LEWIS, JM ;
BENGELE, H .
MAGNETIC RESONANCE IMAGING, 1990, 8 (05) :637-646